Enovis (ENOV) Income from Non-Controlling Interests (2012 - 2026)
Enovis (ENOV) reported Income from Non-Controlling Interests of $314000.0 for Q2 2026, up 20.31% year-over-year from $261000.0 in Q2 2025, and up 132.59% quarter-over-quarter from $135000.0 in Q4 2025.
Enovis (ENOV) Income from Non-Controlling Interests (2012 - 2026) Analysis & Trends
Enovis (ENOV) has 15 years of Income from Non-Controlling Interests data on file, last reported at $314000.0 in Q2 2026.
- Income from Non-Controlling Interests for Q2 2026 came in at $314000.0, up 20.31% year-over-year; the trailing twelve-month figure through Apr 2026 was $873000.0 (up 11.49% YoY), and the FY2025 annual result was $820000.0, up 20.77% from the prior year.
- Income from Non-Controlling Interests grew to $314000.0 in Q2 2026 per ENOV's latest filing, from $135000.0 in the prior quarter.
- Over five years, Income from Non-Controlling Interests peaked at $314000.0 in Q2 2026 and troughed at $34000.0 in Q4 2022.
- A 5-year average of $169411.8 and a median of $157000.0 in 2024 frame the typical range for Income from Non-Controlling Interests.
- The sharpest annual moves came in 2022 and 2024: Income from Non-Controlling Interests tumbled 84.26% in 2022, then surged 547.5% in 2024.
- A 5-year view of Income from Non-Controlling Interests shows it stood at $34000.0 in 2022, then surged by 241.18% to $116000.0 in 2023, then increased by 18.1% to $137000.0 in 2024, then retreated by 1.46% to $135000.0 in 2025, then jumped by 132.59% to $314000.0 in 2026.
- Business Quant data shows ENOV's Income from Non-Controlling Interests at $314000.0 in Q2 2026, $135000.0 in Q4 2025, and $233000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 6.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -5.85 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 22.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 100,000.00 |
| 10 | Enovis | 1.26 Bn | 1.23 Bn | 365.49 Mn | 314,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 314,000.00 |
| Dec 31, 2025 | 135,000.00 |
| Oct 3, 2025 | 233,000.00 |
| Jul 4, 2025 | 191,000.00 |
| Apr 4, 2025 | 261,000.00 |
| Dec 31, 2024 | 137,000.00 |
| Sep 27, 2024 | 259,000.00 |
| Jun 28, 2024 | 126,000.00 |
| Mar 29, 2024 | 157,000.00 |
| Dec 31, 2023 | 116,000.00 |
| Sep 29, 2023 | 40,000.00 |
| Jun 30, 2023 | 182,000.00 |
| Mar 31, 2023 | 192,000.00 |
| Dec 31, 2022 | 34,000.00 |
| Sep 30, 2022 | 136,000.00 |
| Jul 1, 2022 | 100,000.00 |
| Apr 1, 2022 | 267,000.00 |
| Dec 31, 2021 | 216,000.00 |
| Oct 1, 2021 | 818,000.00 |
| Jul 2, 2021 | 355,000.00 |